Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Shunt Failure-The First 30 Days.

Lee RP, Ajmera S, Thomas F, Dave P, Lillard JC, Wallace D, Broussard A, Motiwala M, Norrdahl SP, Venable GT, Khan NR, Harrell C, Jones TL, Vaughn BN, Gooldy T, Hersh DS, Klimo P.

Neurosurgery. 2019 Sep 26. pii: nyz379. doi: 10.1093/neuros/nyz379. [Epub ahead of print]

PMID:
31557298
2.

Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.

Volarevic V, Markovic BS, Jankovic MG, Djokovic B, Jovicic N, Harrell CR, Fellabaum C, Djonov V, Arsenijevic N, Lukic ML.

Theranostics. 2019 Aug 14;9(20):5976-6001. doi: 10.7150/thno.33959. eCollection 2019.

3.

Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis.

Volarevic V, Zdravkovic N, Harrell CR, Arsenijevic N, Fellabaum C, Djonov V, Lukic ML, Simovic Markovic B.

Cells. 2019 Jul 12;8(7). pii: E709. doi: 10.3390/cells8070709.

4.

Reducing Time to Pain Medication Administration for Pediatric Patients with Long Bone Fractures in the Emergency Department.

Schuman SS, Regen RB, Stuart LH, Harrell C, Jones TL, Stewart BM, Berg AM, Longjohn M, Kink RJ.

Pediatr Qual Saf. 2018 Nov 15;3(6):e120. doi: 10.1097/pq9.0000000000000120. eCollection 2018 Nov-Dec.

5.

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives.

Harrell CR, Sadikot R, Pascual J, Fellabaum C, Jankovic MG, Jovicic N, Djonov V, Arsenijevic N, Volarevic V.

Stem Cells Int. 2019 May 2;2019:4236973. doi: 10.1155/2019/4236973. eCollection 2019. Review.

6.

Molecular Mechanisms Responsible for Anti-inflammatory and Immunosuppressive Effects of Mesenchymal Stem Cell-Derived Factors.

Harrell CR, Jankovic MG, Fellabaum C, Volarevic A, Djonov V, Arsenijevic A, Volarevic V.

Adv Exp Med Biol. 2019;1084:187-206. doi: 10.1007/5584_2018_306.

PMID:
31175638
7.

Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.

Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V.

Cells. 2019 May 16;8(5). pii: E467. doi: 10.3390/cells8050467. Review.

8.

Concurrent Use of Calcium Chloride and Arginine Vasopressin Infusions in Pediatric Patients with Acute Cardiocirculatory Failure.

Karki KB, Towbin JA, Harrell C, Tansey J, Krebs J, Bigelow W, Saini A, Tadphale SD.

Pediatr Cardiol. 2019 Jun;40(5):1046-1056. doi: 10.1007/s00246-019-02114-2. Epub 2019 May 7.

PMID:
31065757
9.

Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity.

Volarevic V, Djokovic B, Jankovic MG, Harrell CR, Fellabaum C, Djonov V, Arsenijevic N.

J Biomed Sci. 2019 Mar 13;26(1):25. doi: 10.1186/s12929-019-0518-9. Review.

10.

Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.

Harrell CR, Gazdic M, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V.

Curr Stem Cell Res Ther. 2019;14(4):327-336. doi: 10.2174/1574888X14666190222201749.

PMID:
30806325
11.

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract.

Acovic A, Gazdic M, Jovicic N, Harrell CR, Fellabaum C, Arsenijevic N, Volarevic V.

Therap Adv Gastroenterol. 2018 Dec 6;11:1756284818815334. doi: 10.1177/1756284818815334. eCollection 2018. Review.

12.

Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives.

Harrell CR, Markovic BS, Fellabaum C, Arsenijevic A, Volarevic V.

Biomed Pharmacother. 2019 Jan;109:2318-2326. doi: 10.1016/j.biopha.2018.11.099. Epub 2018 Nov 29. Review.

13.

Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis.

Acovic A, Simovic Markovic B, Gazdic M, Arsenijevic A, Jovicic N, Gajovic N, Jovanovic M, Zdravkovic N, Kanjevac T, Harrell CR, Fellabaum C, Dolicanin Z, Djonov V, Arsenijevic N, Lukic ML, Volarevic V.

Therap Adv Gastroenterol. 2018 Aug 24;11:1756284818793558. doi: 10.1177/1756284818793558. eCollection 2018.

14.

Platelet Transfusions in the PICU: Does Disease Severity Matter?

Saini A, West AN, Harrell C, Jones TL, Nellis ME, Joshi AD, Cowan KM, Gatewood CW, Ryder AB, Reiss UM.

Pediatr Crit Care Med. 2018 Sep;19(9):e472-e478. doi: 10.1097/PCC.0000000000001653.

PMID:
29927877
15.

Modulation of autophagy as new approach in mesenchymal stem cell-based therapy.

Jakovljevic J, Harrell CR, Fellabaum C, Arsenijevic A, Jovicic N, Volarevic V.

Biomed Pharmacother. 2018 Aug;104:404-410. doi: 10.1016/j.biopha.2018.05.061. Epub 2018 May 25. Review.

PMID:
29787987
16.

High-fructose diet during adolescent development increases neuroinflammation and depressive-like behavior without exacerbating outcomes after stroke.

Harrell CS, Zainaldin C, McFarlane D, Hyer MM, Stein D, Sayeed I, Neigh GN.

Brain Behav Immun. 2018 Oct;73:340-351. doi: 10.1016/j.bbi.2018.05.018. Epub 2018 May 19.

PMID:
29787857
17.

Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases.

Harrell CR, Simovic Markovic B, Fellabaum C, Arsenijevic A, Djonov V, Arsenijevic N, Volarevic V.

Adv Exp Med Biol. 2018;1089:47-57. doi: 10.1007/5584_2018_219. Review.

PMID:
29774506
18.

Stem Cells Therapy for Spinal Cord Injury.

Gazdic M, Volarevic V, Harrell CR, Fellabaum C, Jovicic N, Arsenijevic N, Stojkovic M.

Int J Mol Sci. 2018 Mar 30;19(4). pii: E1039. doi: 10.3390/ijms19041039. Review.

19.

Molecular mechanisms underlying therapeutic potential of pericytes.

Harrell CR, Simovic Markovic B, Fellabaum C, Arsenijevic A, Djonov V, Volarevic V.

J Biomed Sci. 2018 Mar 9;25(1):21. doi: 10.1186/s12929-018-0423-7. Review.

20.

Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury.

Gazdic M, Markovic BS, Arsenijevic A, Jovicic N, Acovic A, Harrell CR, Fellabaum C, Djonov V, Arsenijevic N, Lukic ML, Volarevic V.

Liver Transpl. 2018 May;24(5):687-702. doi: 10.1002/lt.25049. Epub 2018 Apr 16.

21.

Risks of Using Sterilization by Gamma Radiation: The Other Side of the Coin.

Harrell CR, Djonov V, Fellabaum C, Volarevic V.

Int J Med Sci. 2018 Jan 18;15(3):274-279. doi: 10.7150/ijms.22644. eCollection 2018. Review.

22.

Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis.

Arsenijevic A, Harrell CR, Fellabaum C, Volarevic V.

Anal Cell Pathol (Amst). 2017;2017:7492836. doi: 10.1155/2017/7492836. Epub 2017 Dec 19. Review.

23.

Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases.

Markovic BS, Kanjevac T, Harrell CR, Gazdic M, Fellabaum C, Arsenijevic N, Volarevic V.

Stem Cell Rev Rep. 2018 Apr;14(2):153-165. doi: 10.1007/s12015-017-9789-2. Review.

PMID:
29177796
24.

Testing for Urinary Tract Infection in the Influenza/Respiratory Syncytial Virus-Positive Febrile Infant Aged 2 to 12 Months.

Schlechter Salinas AK, Hains DS, Jones T, Harrell C, Meredith M.

Pediatr Emerg Care. 2019 Oct;35(10):666-670. doi: 10.1097/PEC.0000000000001073.

PMID:
28277411
25.

Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists.

Skudlarek JW, DiMarco CN, Babaoglu K, Roecker AJ, Bruno JG, Pausch MA, O'Brien JA, Cabalu TD, Stevens J, Brunner J, Tannenbaum PL, Wuelfing WP, Garson SL, Fox SV, Savitz AT, Harrell CM, Gotter AL, Winrow CJ, Renger JJ, Kuduk SD, Coleman PJ.

Bioorg Med Chem Lett. 2017 Mar 15;27(6):1364-1370. doi: 10.1016/j.bmcl.2017.02.012. Epub 2017 Feb 9.

PMID:
28216403
26.

Baby Boomers and Birth Certificates: Early-Life Socioeconomic Status and Cancer Risk in Adulthood.

Stroup AM, Herget KA, Hanson HA, Reed DL, Butler JT, Henry KA, Harrell CJ, Sweeney C, Smith KR.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):75-84. doi: 10.1158/1055-9965.EPI-16-0371. Epub 2016 Sep 21.

27.

Neuroinflammation and Behavior in HIV-1 Transgenic Rats Exposed to Chronic Adolescent Stress.

Rowson SA, Harrell CS, Bekhbat M, Gangavelli A, Wu MJ, Kelly SD, Reddy R, Neigh GN.

Front Psychiatry. 2016 Jun 20;7:102. doi: 10.3389/fpsyt.2016.00102. eCollection 2016.

28.

Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.

Gotter AL, Forman MS, Harrell CM, Stevens J, Svetnik V, Yee KL, Li X, Roecker AJ, Fox SV, Tannenbaum PL, Garson SL, Lepeleire ID, Calder N, Rosen L, Struyk A, Coleman PJ, Herring WJ, Renger JJ, Winrow CJ.

Sci Rep. 2016 Jun 3;6:27147. doi: 10.1038/srep27147.

29.

Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors.

Yin J, Babaoglu K, Brautigam CA, Clark L, Shao Z, Scheuermann TH, Harrell CM, Gotter AL, Roecker AJ, Winrow CJ, Renger JJ, Coleman PJ, Rosenbaum DM.

Nat Struct Mol Biol. 2016 Apr;23(4):293-9. doi: 10.1038/nsmb.3183. Epub 2016 Mar 7.

PMID:
26950369
30.

Energetic stress: The reciprocal relationship between energy availability and the stress response.

Harrell CS, Gillespie CF, Neigh GN.

Physiol Behav. 2016 Nov 1;166:43-55. doi: 10.1016/j.physbeh.2015.10.009. Epub 2015 Oct 9. Review.

31.

High-fructose diet during periadolescent development increases depressive-like behavior and remodels the hypothalamic transcriptome in male rats.

Harrell CS, Burgado J, Kelly SD, Johnson ZP, Neigh GN.

Psychoneuroendocrinology. 2015 Dec;62:252-64. doi: 10.1016/j.psyneuen.2015.08.025. Epub 2015 Sep 7.

32.

Pharmacological stimulation of hypoxia inducible factor-1α facilitates the corticosterone response to a mild acute stressor.

Harrell CS, Rowson SA, Neigh GN.

Neurosci Lett. 2015 Jul 23;600:75-9. doi: 10.1016/j.neulet.2015.05.051. Epub 2015 May 29.

33.

Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties.

Kuduk SD, Skudlarek JW, DiMarco CN, Bruno JG, Pausch MH, O'Brien JA, Cabalu TD, Stevens J, Brunner J, Tannenbaum PL, Garson SL, Savitz AT, Harrell CM, Gotter AL, Winrow CJ, Renger JJ, Coleman PJ.

Bioorg Med Chem Lett. 2015 Jun 15;25(12):2488-92. doi: 10.1016/j.bmcl.2015.04.066. Epub 2015 Apr 29.

PMID:
25981685
34.

Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements.

Roecker AJ, Mercer SP, Bergman JM, Gilbert KF, Kuduk SD, Harrell CM, Garson SL, Fox SV, Gotter AL, Tannenbaum PL, Prueksaritanont T, Cabalu TD, Cui D, Lemaire W, Winrow CJ, Renger JJ, Coleman PJ.

Bioorg Med Chem Lett. 2015 Nov 1;25(21):4992-4999. doi: 10.1016/j.bmcl.2014.12.081. Epub 2015 Jan 6.

PMID:
25613676
35.

Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant.

Raheem IT, Breslin MJ, Bruno J, Cabalu TD, Cooke A, Cox CD, Cui D, Garson S, Gotter AL, Fox SV, Harrell CM, Kuduk SD, Lemaire W, Prueksaritanont T, Renger JJ, Stump C, Tannenbaum PL, Williams PD, Winrow CJ, Coleman PJ.

Bioorg Med Chem Lett. 2015 Feb 1;25(3):444-50. doi: 10.1016/j.bmcl.2014.12.056. Epub 2014 Dec 23.

PMID:
25577040
36.

An age-period-cohort analysis of cancer incidence among the oldest old, Utah 1973-2002.

Hanson HA, Smith KR, Stroup AM, Harrell CJ.

Popul Stud (Camb). 2015;69(1):7-22. doi: 10.1080/00324728.2014.958192. Epub 2014 Nov 14.

37.

Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats.

Nemeth CL, Glasper ER, Harrell CS, Malviya SA, Otis JS, Neigh GN.

PLoS One. 2014 Oct 1;9(10):e108399. doi: 10.1371/journal.pone.0108399. eCollection 2014.

38.

Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia.

Roecker AJ, Reger TS, Mattern MC, Mercer SP, Bergman JM, Schreier JD, Cube RV, Cox CD, Li D, Lemaire W, Bruno JG, Harrell CM, Garson SL, Gotter AL, Fox SV, Stevens J, Tannenbaum PL, Prueksaritanont T, Cabalu TD, Cui D, Stellabott J, Hartman GD, Young SD, Winrow CJ, Renger JJ, Coleman PJ.

Bioorg Med Chem Lett. 2014 Oct 15;24(20):4884-90. doi: 10.1016/j.bmcl.2014.08.041. Epub 2014 Aug 26.

PMID:
25248679
39.

Two weeks of predatory stress induces anxiety-like behavior with co-morbid depressive-like behavior in adult male mice.

Burgado J, Harrell CS, Eacret D, Reddy R, Barnum CJ, Tansey MG, Miller AH, Wang H, Neigh GN.

Behav Brain Res. 2014 Dec 15;275:120-5. doi: 10.1016/j.bbr.2014.08.060. Epub 2014 Sep 6.

40.

Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis.

Roecker AJ, Mercer SP, Harrell CM, Garson SL, Fox SV, Gotter AL, Prueksaritanont T, Cabalu TD, Cui D, Lemaire W, Winrow CJ, Renger JJ, Coleman PJ.

Bioorg Med Chem Lett. 2014 May 1;24(9):2079-85. doi: 10.1016/j.bmcl.2014.03.052. Epub 2014 Mar 26.

PMID:
24704030
41.

Ovarian steroids influence cerebral glucose transporter expression in a region- and isoform-specific pattern.

Harrell CS, Burgado J, Kelly SD, Neigh GN.

J Neuroendocrinol. 2014 Apr;26(4):217-25. doi: 10.1111/jne.12139.

42.

Prediction equation to estimate dead space to tidal volume fraction correlates with mortality in critically ill patients.

Vender RL, Betancourt MF, Lehman EB, Harrell C, Galvan D, Frankenfield DC.

J Crit Care. 2014 Apr;29(2):317.e1-3. doi: 10.1016/j.jcrc.2013.12.009. Epub 2013 Dec 30.

PMID:
24581935
43.

Chronic stress modulates regional cerebral glucose transporter expression in an age-specific and sexually-dimorphic manner.

Kelly SD, Harrell CS, Neigh GN.

Physiol Behav. 2014 Mar 14;126:39-49. doi: 10.1016/j.physbeh.2013.12.002. Epub 2013 Dec 29.

44.

Discovery of 5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia.

Roecker AJ, Mercer SP, Schreier JD, Cox CD, Fraley ME, Steen JT, Lemaire W, Bruno JG, Harrell CM, Garson SL, Gotter AL, Fox SV, Stevens J, Tannenbaum PL, Prueksaritanont T, Cabalu TD, Cui D, Stellabott J, Hartman GD, Young SD, Winrow CJ, Renger JJ, Coleman PJ.

ChemMedChem. 2014 Feb;9(2):311-22. doi: 10.1002/cmdc.201300447. Epub 2013 Dec 27.

PMID:
24376006
45.

Estradiol activates epithelial sodium channels in rat alveolar cells through the G protein-coupled estrogen receptor.

Greenlee MM, Mitzelfelt JD, Yu L, Yue Q, Duke BJ, Harrell CS, Neigh GN, Eaton DC.

Am J Physiol Lung Cell Mol Physiol. 2013 Dec;305(11):L878-89. doi: 10.1152/ajplung.00008.2013. Epub 2013 Oct 4.

46.

The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold.

Gotter AL, Winrow CJ, Brunner J, Garson SL, Fox SV, Binns J, Harrell CM, Cui D, Yee KL, Stiteler M, Stevens J, Savitz A, Tannenbaum PL, Tye SJ, McDonald T, Yao L, Kuduk SD, Uslaner J, Coleman PJ, Renger JJ.

BMC Neurosci. 2013 Aug 28;14:90. doi: 10.1186/1471-2202-14-90.

47.

Not all depression is created equal: sex interacts with disease to precipitate depression.

Nemeth CL, Harrell CS, Beck KD, Neigh GN.

Biol Sex Differ. 2013 Apr 17;4(1):8. doi: 10.1186/2042-6410-4-8.

48.

Sex and lineage interact to predict behavioral effects of chronic adolescent stress in rats.

Harrell CS, Hardy E, Boss-Williams K, Weiss JM, Neigh GN.

Behav Brain Res. 2013 Jul 1;248:57-61. doi: 10.1016/j.bbr.2013.04.003. Epub 2013 Apr 11.

49.

Sex differences in the effects of adolescent stress on adult brain inflammatory markers in rats.

Pyter LM, Kelly SD, Harrell CS, Neigh GN.

Brain Behav Immun. 2013 May;30:88-94. doi: 10.1016/j.bbi.2013.01.075. Epub 2013 Jan 21.

50.

Long-term survival in young women: hazards and competing risks after thyroid cancer.

Stroup AM, Harrell CJ, Herget KA.

J Cancer Epidemiol. 2012;2012:641372. doi: 10.1155/2012/641372. Epub 2012 Oct 2.

Supplemental Content

Loading ...
Support Center